Our results are also in accordance with work recently published by Lin et al. examining the role of GALNT6 in ES-2 ovarian cancer cells [11], as their results confirm the effect of GALNT6 inhibition on the downregulation of various pathways, including cell cycle, cell migration, and major PTMs such as protein phosphorylation [11]. This evidence concerns the gene GALNT6 and ovarian cancer.